[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-525917-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-525917-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","mass-spectrometrybased-identication-of-mhc-bound-peptides-for-immunopeptidomics-protocol","Mass spectrometry–based identiﬁcation of MHC-bound peptides for immunopeptidomics - Protocol","","Peptide antigens bound to major histocompatibility complex (MHC) molecules are presented on the cell surface and recognized by T lymphocytes, enabling eradication of infected and cancerous cells and supporting antibody production. The document provides a robust protocol to identify MHC-bound peptides from cell lines and tissues using nano-ultra-performance liquid chromatography coupled to high-resolution mass spectrometry (nUPLC–MS/MS). It details immunoafﬁnity capture, acid denaturation to dissociate class I HLA peptides, HPLC fractionation, and peptide identification, reporting thousands of peptides per run with a 2–3 day turnaround.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/mass-spectrometrybased-identication-of-mhc-bound-peptides-for-immunopeptidomics-protocol/525917/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/mass-spectrometrybased-identication-of-mhc-bound-peptides-for-immunopeptidomics-protocol/525917.png","ImageObject",300,407,{"name":42,"@type":43},"Hazel","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-17","2026-10-08",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",14,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the purpose of identifying MHC-bound peptides in immunopeptidomics?","Question",{"text":63,"@type":64},"To determine peptide antigens presented on cell surfaces that drive adaptive immune recognition. This supports development of vaccines by enabling effective immune responses and durable immune memory.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How does the protocol isolate MHC-peptide complexes before mass spectrometry?",{"text":68,"@type":64},"It begins with immunoaffinity capture of naturally processed MHC–peptide complexes. Peptides are then released from class I HLA molecules by acid denaturation and prepared for separation.",{"name":70,"@type":61,"acceptedAnswer":71},"What analytical workflow is used to identify the extracted peptides?",{"text":72,"@type":64},"After extraction, peptides are separated into fractions by HPLC and identified using nUPLC–MS/MS. The approach can identify several thousand peptides from diverse cell types and tissues within 2–3 days.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},525917,1791633706,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":140,"language":141,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":12,"update_tm":145,"read_time":146,"preview_page_count":33,"preview_urls":147},137441390410,"https://ap-avatar.wpscdn.com/avatar/2000252f4ab5702993?_k=1776741390130283984","PROTOCOL  \n[https://doi.org/10.1038/s41596-019-0133-y](https://doi.org/10.1038/s41596-019-0133-y)  \nMass spectrometry–based identiﬁcation of MHC-bound peptides for immunopeptidomics  \nAnthony W. Purcell 1*, Sri H. Ramarathinam 1 and Nicola Ternette2*  \nPeptide antigens bound to molecules encoded by the major histocompatibility complex (MHC) and presented on the cell surface form the targets of T lymphocytes. This critical arm of the adaptive immune system facilitates the eradication of pathogen-infected and cancerous cells, as well as the production of antibodies. Methods to identify these peptide antigens are critical to the development of new vaccines, for which the goal is the generation of effective adaptive immune responses and long-lasting immune memory. Here, we describe a robust protocol for the identiﬁcation of MHC-bound peptides from cell lines and tissues, using nano-ultra-performance liquid chromatography coupled to high-resolution mass spectrometry (nUPLC–MS/MS) and recent improvements in methods for isolation and characterization of these peptides. The protocol starts with the immunoafﬁnity capture of naturally processed MHC-peptide complexes. The peptides dissociate from the class I human leukocyte antigens (HLAs) upon acid denaturation. This peptide cargo is then extracted and separated into fractions by HPLC, and the peptides in these fractions are identiﬁed using nUPLC–MS/MS. With this protocol, several thousand peptides can be identiﬁed from a wide variety of cell types, including cancerous and infected cells and those from tissues, with a turnaround time of 2–3 d.  \nIntroduction  \nThe recognition of foreign antigens by T lymphocytes is the cornerstone of adaptive immunity. Speciﬁcally, intracellular antigens are degraded in the cytosol and antigenic precursor peptides are transported to the endoplasmic reticulum, where they are further trimmed to short peptides (8–11 amino acids (aa)) that can assemble with class I HLAs. These peptide–HLA class I complexes egress to the cell surface and are scrutinized by CD8+ T cells for foreign antigens that differ from the pool of peptides presented in a healthy cellular environment. Identiﬁcation of a pathogenic, mutated or otherwise distinct antigen will eventually lead to the eradication of the affected cell through the cytotoxic arsenal of these immune effector cells. Alternatively, exogenous antigens can be taken up by professional antigen-presenting cells and degraded in the endosomal compartments of the cell. The resultant peptides (10–20 aa) can be subsequently sampled by class II HLA molecules and presented on the surface of these cells. Recognition of these complexes by antigen-speciﬁc CD4+ T cells leads to T-cell activation and the generation of a humoral immune response. This central role played by peptides in immunity has driven efforts to not only identify the antigens that are targeted by immunity but also the HLA-bound peptides that determine the speciﬁcity, magnitude and quality of the ensuing immune response.  \nUnlike standard proteomic workﬂows, in which peptides generated from deliberate proteolytic digestion of proteinaceous samples are identiﬁed by mass spectrometry, studies of HLA-bound peptides (immunopeptidomics) are considerably more challenging for a number of reasons: ﬁrst, the precise proteolytic mechanism for generating the mature peptide–HLA complex is unknown and complex (many proteases and peptidases can be involved in liberating the peptide from the mature antigen complex) (Fig. 1); second, the peptides that bind to HLA molecules are more similar to eachother in terms of length and sequence conservation as compared with enzyme-digested protein material; and, ﬁnally, the relatively low abundance of HLA-bound peptides, as compared with that of the intact source antigen, makes their detection more difﬁcult1. Thus, historically, the biochemical identiﬁcation of HLA-bound peptides has been the domain of a few specialized laboratories and, unl","cbCailQob8wsBNe3","https://ap.wps.com/l/cbCailQob8wsBNe3","pdf",1765291,21,"English","# Introduction\n## Adaptive immunity and peptide–HLA recognition\n## Challenges in immunopeptidomics\n## Overview of the protocol workflow","[{\"question\":\"What is the purpose of identifying MHC-bound peptides in immunopeptidomics?\",\"answer\":\"To determine peptide antigens presented on cell surfaces that drive adaptive immune recognition. This supports development of vaccines by enabling effective immune responses and durable immune memory.\"},{\"question\":\"How does the protocol isolate MHC-peptide complexes before mass spectrometry?\",\"answer\":\"It begins with immunoaffinity capture of naturally processed MHC–peptide complexes. Peptides are then released from class I HLA molecules by acid denaturation and prepared for separation.\"},{\"question\":\"What analytical workflow is used to identify the extracted peptides?\",\"answer\":\"After extraction, peptides are separated into fractions by HPLC and identified using nUPLC–MS/MS. The approach can identify several thousand peptides from diverse cell types and tissues within 2–3 days.\"}]","Mass spectrometry–based identiﬁcation of MHC-bound peptides for immunopeptidomics - Protocol | PDF",1791493960,53,[148,152,156,160],{"page_no":22,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-17/38e202e55c3507054b91653ef58bd36d.webp",983,1305,{"page_no":26,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-17/185c105d33b3487fd3c98c604a69bd26.webp",982,1304,{"page_no":30,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-17/0587cd0fc5ba5355dd1f05a091b13355.webp",981,1303,{"page_no":33,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-17/84a836017a93312b8fc9bb718e6b8198.webp",980,1301]